Dr. Eknath D. Ahire is an Assistant Professor in the Department of Pharmaceutics at MET’s Institute of Pharmacy, Nashik, Maharashtra, India. He holds an MS in Pharmaceutics from NIPER-A and a PhD from Savitribai Phule Pune University. He also serves as a part-time Pre-shipment Inspector for QCS Labs LLP, Mumbai.
He has received AICTE, JRF and SRF fellowships from the Government of India. His achievements include the Outstanding Reviewer Award from Trends in Sciences, Thailand, with a cash prize of THB 20,000, and Third Prize in the Pharmaceutical Category at the Dr. P. D. Sethi National HPTLC Awards 2025. He was also invited by the Ministry of Tribal Affairs to participate in an interactive meeting with the Hon’ble President of India on 2 June 2026.
With over nine years of academic and industrial experience, he has completed 430+ verified peer reviews for 55+ journals. He serves in editorial roles with Scientific Reports (Springer Nature), Frontiers journals, Acta Scientific, and Community Acquired Infection. He is a life member of APTI.
His research contributions include 140+ publications (H-index: 22), 10 textbooks, 7 edited international books, 3 patents, and 1 copyright. His research interests include pharmaceutical formulation development, cancer research, nanotechnology-based drug delivery, antimicrobial resistance, and nutraceuticals.
Dr. Eknath D. Ahire is an Assistant Professor in the Department of Pharmaceutics at MET’s Institute of Pharmacy, Nashik, Maharashtra, India. He holds an MS in Pharmaceutics from NIPER-A and a PhD from Savitribai Phule Pune University. He also serves as a part-time Pre-shipment Inspector for QCS Labs LLP, Mumbai.
He has received AICTE, JRF and SRF fellowships from the Government of India. His achievements include the Outstanding Reviewer Award from Trends in Sciences, Thailand, with a cash prize of THB 20,000, and Third Prize in the Pharmaceutical Category at the Dr. P. D. Sethi National HPTLC Awards 2025. He was also invited by the Ministry of Tribal Affairs to participate in an interactive meeting with the Hon’ble President of India on 2 June 2026.
With over nine years of academic and industrial experience, he has completed 430+ verified peer reviews for 55+ journals. He serves in editorial roles with Scientific Reports (Springer Nature), Frontiers journals, Acta Scientific, and Community Acquired Infection. He is a life member of APTI.
His research contributions include 140+ publications (H-index: 22), 10 textbooks, 7 edited international books, 3 patents, and 1 copyright. His research interests include pharmaceutical formulation development, cancer research, nanotechnology-based drug delivery, antimicrobial resistance, and nutraceuticals.